OPA Bulletin

  • OPA Bulletin - October 17, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Update from OPA on Fluzone® High-Dose
    • OPDP Notice No. 18128 posted October 12, 2018 Prescription Forgery Alert
    • Happy National Pharmacy Technician Day (October 16, 2018)
    • Highlights in Professional Development​​
    • Methadone and Breastfeeding
    • Medical Assistance in Dying (MAiD) - New Federal Regulations Come Into Effect November 1, 2018 for Healthcare Practitioners
    • University of Waterloo Conducting Research on Community Pharmacists’ Knowledge, Skills and Judgment in the Assessment and Management of Headaches
    • Queen's University and Ontario College of Family Physicians Looking for MAiD Pharmacists Research

  • OPA Bulletin - October 2, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Drug Supply Health System Alert: Vitamin K Injection
    • OPDP Notice No.18120 posted September 27, 2018 Prescription Forgery Alert
    • Prescription Forgery Alert
    • Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients
    • Advocacy at OPA
    • It's Customer Service Week -- Take a Moment to Thank Our DIRC, PSN and CEA Teams
    • Highlights in Professional Development​​
    • And more

  • OPA Bulletin - September 25, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Drug Supply Health System Alert: Fludarabine & Vinorelbine
    • OPDP Notice No. 18114 posted September 20, 2018 ODB FORMULARY – EDITION NO. 43, Summary of Changes – September 2018
    • OPDP Notice No. 18115 posted September 20, 2018 Notice from the Executive Officer: Funding of Glatect (glatiramer acetate) under the Ontario Drug Benefit Program
    • OPDP Notice No. 18116 posted September 20, 2018 Notice from the Executive Officer: Funding of Renflexis (infliximab) under the Ontario Drug Benefit Program
    • OPDP Notice No. 18117 posted September 21, 2018 Canada Post Labour Disruption - Ontario Drug Benefit Contingency Plan
    • OPDP Notice No. 18118 posted September 25, 2018 Notice from the Executive Officer: Update on Claims Submission for Valved Holding Chambers through the Ontario Drug Benefit Program
    • And more

  • OPA Bulletin - September 18, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Drug Supply Health System Alert: Sodium Bicarbonate Injection USP 8.4%, 10 x 50mL vials
    • Express Scripts Canada Correction Notice - Valsartan Recall
    • OPDP Notice No. 18113 posted September 18, 2018 Prescription Forgery Alert
    • OPA Launches Cannabis Tools for Use in Pharmacy Practice
    • Highlights in Professional Development​​
    • Ask the Practice Support Network
    • OPA Secure Health Plan - Reduced Premium Changes

  • OPA Bulletin - September 11, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPDP Notice No. 18016A posted on September 7, 2018
    • OPDP Notice No. 18110 posted on September 10, 2018 Notice from the Executive Officer: Availability and Funding of AUVI-Q® (Epinephrine Auto-Injectors)
    • Highlights in Professional Development​​
    • Ask the Customer Experience and Administration Team
    • September Marketing Materials for Pharmacy Professionals
    • Life Insurance v.s. Mortgage Insurance

  • OPA Bulletin - September 4, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Health Canada Advisory -- Epinephrine Update
    • OPDP Notice No. 18106 posted August 31, 2018 Prescription Forgery Alert
    • Highlights in Professional Development​​
    • OPA Term 10 Life Insurance Convertible Feature
    • OPA Students - Take Our Survey
    • Car Shopping?

  • OPA Bulletin - August 28, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPDP Notice No. 18103 posted August 23, 2018 ODB Formulary – Edition No. 43, Summary of Changes – August 2018
    • OPDP Notice No. 18104 posted August 27, 2018 Prescription Forgery Alert
    • Drug Supply Health System Alert: EpiPen Auto-Injector (0.3mg and 0.15mg)
    • Drug Shortage Health System Alert: IV Fludarabine Update
    • Highlights in Professional Development​​
    • Ask the Customer Experience Team
    • Naloxone for Back-to-School
    • And more

  • OPA Bulletin - August 21, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Health Canada - Recall Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
    • OPDP Notice No. 18100 posted August 15, 2018 Prescription Forgery Alert
    • OPDP Notice No. 18101 posted August 20, 2018 Prescription Forgery Alert
    • OPDP Notice No. 18102 posted August 20, 2018 Prescription Forgery Alert
    • Drug Supply Alert - Docetaxel
    • Drug Shortage Alert - Fludarabine
    • Highlights in Professional Development​​
    • Apply for Allied Health Professional Fund for Professional Development
    • And more

  • OPA Bulletin - August 14, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPDP Notice No. 18098 posted August 13, 2018 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to ODP Agencies
    • OPDP Notice No. 18099 posted August 14, 2018 Notice from the Executive Officer: Claim Submission/Reversal and Special Authorization (Allergen) forms
    • Recent Ontario Government Prompts OPA to Reinforce Request for Policy Changes to Allow Pharmacists to Dispense Medicinal Cannabis
    • Highlights in Professional Development​​
    • Apply for Allied Health Professional Fund for Professional Development Needs
    • Ask the Customer Experience and Administration Team
    • Is Your Financial Future in Order?
    • OPA Members Save 10% on Pharmacist's Letter Canada

  • OPA Bulletin - August 7, 2018

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPDP Notice No. 18092 posted August 1, 2018 Drug Shortage of EpiPen® 0.3mg Auto-Injectors
    • Highlights in Professional Development​​
    • Apply for Allied Health Professional Fund for Professional Development Needs
    • Ask the Practice Support Network
    • "Must Have Insurance" to Protect Your Most Valuable Asset
    • Let's Go to the Ex!

Back to top